ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ASMB Company Profile and Key Details

NASDAQ : ASMB

Assembly Biosciences, Inc.

$10.79

-0.2482-2.25%

Open: 1:42 PM

57.89

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ASMB Stock Price Chart

Stock Price Today

Assembly Biosciences, Inc. (ASMB) stock declined over -2.25%, trading at $10.79 on NASDAQ, down from the previous close of $11.04. The stock opened at $11.07, fluctuating between $10.79 and $11.07 in the recent session.

Stock Snapshot

11.04

Prev. Close

11.07

Open

68.6M

Market Cap

6.36M

Number of Shares

10.7918

Day Low

11.0696

Day High

-1.57

P/E Ratio

52.68%

Free Float in %

-6.89

EPS (TTM)

7.5

Book Value

4.1

Cash Flow per Share

2.35K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 12, 2025	11.02	11.41	10.90	11.04	9.13K
Mar 11, 2025	11.18	11.18	10.56	10.81	15.63K
Mar 10, 2025	11.35	11.89	10.80	10.92	20.16K
Mar 07, 2025	11.50	11.90	10.89	11.12	37.37K
Mar 06, 2025	11.90	11.94	11.30	11.43	33.65K
Mar 05, 2025	12.08	12.14	11.23	11.98	26.51K
Mar 04, 2025	12.23	12.23	11.27	11.95	29.03K
Mar 03, 2025	13.07	13.07	12.23	12.23	20.53K
Feb 28, 2025	12.90	12.90	12.53	12.88	10.35K
Feb 27, 2025	13.37	13.37	12.77	12.97	8.91K
Feb 26, 2025	12.50	13.54	12.41	13.31	29.73K
Feb 25, 2025	12.62	12.81	12.20	12.34	50.8K
Feb 24, 2025	12.87	13.00	12.36	12.55	42.1K
Feb 21, 2025	12.70	13.04	12.35	12.35	21.2K
Feb 20, 2025	13.10	13.75	12.35	12.75	44K
Feb 19, 2025	12.49	13.33	12.43	12.73	37.73K
Feb 18, 2025	12.80	12.82	12.31	12.48	37.78K
Feb 14, 2025	12.50	13.25	12.25	13.02	48.61K
Feb 13, 2025	12.60	12.75	12.10	12.21	22.79K
Feb 12, 2025	13.00	13.00	12.50	12.57	29.61K

Contact Details

South San Francisco, CA 94080

United States

Website: https://www.assemblybio.comContact: 833 509 4583

About Company

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. It also has strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Frequently Asked Questions

What is the current Assembly Biosciences, Inc. (ASMB) stock price?

Assembly Biosciences, Inc. (NASDAQ: ASMB) stock price is $10.79 in the last trading session. During the trading session, ASMB stock reached the peak price of $11.07 while $10.79 was the lowest point it dropped to. The percentage change in ASMB stock occurred in the recent session was -2.25% while the dollar amount for the price change in ASMB stock was -$0.25.

ASMB's industry and sector of operation?

The NASDAQ listed ASMB is part of Biotechnology industry that operates in the broader Healthcare sector. Assembly Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ASMB?

Dr. William E. Delaney IV, Ph.D.
Chief Scientific Officer
Ms. Michele Anderson
Chief Devel. Officer
Amy Figueroa C.F.A.
Investor Relations Consultant
Dr. John G. McHutchison A.O., FRACP, M.D.
Chief Executive Officer & Director
Ms. Jennifer A. Troia MHROD, SHRM-SCP, SPHR
Chief HR Officer
Dr. Adam Zlotnick
Co-Founder, Chief Scientific Advisor and Chair of Hbv & Virology Science Advisory Board
Mr. Jason A. Okazaki
Chief Operating Officer, Chief Executive Officer, Pres & Director
Mr. Thomas E. Rollins
Executive Officer
Dr. Tharaknath Rao
Head of Microbiome Clinical Devel. & Senior Vice President
Dr. Nicole S. White Ph.D.
Chief Manufacturing Officer
Dr. Richard J. Colonno
Senior Advisor
Jeanette M Bjorkquist
Executive Director of Accounting & Treasury
Shannon Ryan
Senior Vice President of Investor Relations, Corporation Affairs & Alliance Management

How ASMB did perform over past 52-week?

ASMB's closing price is 4.54% higher than its 52-week low of $10.56 where as its distance from 52-week high of $19.93 is -44.61%.

How many employees does ASMB have?

Number of ASMB employees currently stands at 65.

Link for ASMB official website?

Official Website of ASMB is: https://www.assemblybio.com

How do I contact ASMB?

ASMB could be contacted at phone 833 509 4583 and can also be accessed through its website. ASMB operates from 331 Oyster Point Boulevard, South San Francisco, CA 94080, United States.

How many shares of ASMB are traded daily?

ASMB stock volume for the day was 2.35K shares. The average number of ASMB shares traded daily for last 3 months was 30.66K.

What is the market cap of ASMB currently?

The market value of ASMB currently stands at $68.60M with its latest stock price at $10.79 and 6.36M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	65
Beta	0.63
Sales or Revenue	$7.16M
5Y Sales Change%	1.41%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology